Accurate preoperative identification of lateral cervical lymph node metastasis (LNM) is important for decision-making and clinical management of patients with papillary thyroid carcinoma (PTC). The aim of this study was to develop an ultrasound (US)-based radiomic nomogram to preoperatively predict the lateral LNM in PTC patients. In this retrospective study, a total of 886 patients were enrolled and randomly divided into 2 groups. Radiomic features were extracted from the preoperative US images. A radiomic signature was constructed using the least absolute shrinkage and selection operator algorithm in the training set. Multivariate logistic regression was performed to develop the radiomic nomogram, which incorporating the radiomic signature and the selected clinical characteristics. The performance of the nomogram was assessed by its discrimination, calibration, and clinical usefulness in both the training and validation sets. The radiomic signature was significantly associated with the lateral LNM in both cohorts (p< 0.001). The nomogram that consisted of radiomic signature, US-reported cervical lymph node (CLN) status, and CT-reported CLN status demonstrated good discrimination and calibration in the training and validation sets with an AUC of 0.946 and 0.914, respectively. The decision curve analysis indicated that the radiomic nomogram was worthy of clinical application. The radiomic nomogram proposed here has good performance for noninvasively predicting the lateral LNM and might be used to facilitate clinical decision-making and potentially improve the survival outcome in selected patients.
11 June 2021 in IEEE Transactions on Instrumentation and Measurement
Segmentation of the breast ultrasound (BUS) image is an important step for subsequent assessment and diagnosis of breast lesions. Recently, Deep-learning-based methods have achieved satisfactory performance in many computer vision tasks, especially in medical image segmentation. Nevertheless, those methods always require a large number of pixel-wise labeled data that is expensive in medical practices. In this study, we propose a new segmentation method by dense prediction and local fusion of superpixels for breast anatomy with scarce labeled data. First, the proposed method generates superpixels from the BUS image enhanced by histogram equalization, a bilateral filter, and a pyramid mean shift filter. Second, using a convolutional neural network (CNN) and distance metric learning-based classifier, the superpixels are projected onto the embedding space and then classified by calculating the distance between superpixels' embeddings and the centers of categories. By using superpixels, we can generate a large number of training samples from each BUS image. Therefore, the problem of the scarcity of labeled data can be better solved. To avoid the misclassification of the superpixels, K-nearest neighbor (KNN) is used to reclassify the superpixels within every local region based on the spatial relationships among them. Fivefold cross-validation was taken and the experimental results show that our method outperforms several often used deep-learning methods under the condition of the absence of a large number of labeled data (48 BUS images for training and 12 BUS images for testing).
Purpose: The detection of human epidermal growth factor receptor 2 (HER2) expression status is essential to determining the chemotherapy regimen for breast cancer patients and to improving their prognosis. We developed a deep learning radiomics (DLR) model combining time-frequency domain features of ultrasound (US) video of breast lesions with clinical parameters for predicting HER2 expression status.Patients and Methods: Data for this research was obtained from 807 breast cancer patients who visited from February 2019 to July 2020. Ultimately, 445 patients were included in the study. Pre-operative breast ultrasound examination videos were collected and split into a training set and a test set. Building a training set of DLR models combining time-frequency domain features and clinical features of ultrasound video of breast lesions based on the training set data to predict HER2 expression status. Test the performance of the model using test set data. The final models integrated with different classifiers are compared, and the best performing model is finally selected.Results: The best diagnostic performance in predicting HER2 expression status is provided by an Extreme Gradient Boosting (XGBoost)-based time-frequency domain feature classifier combined with a logistic regression (LR)-based clinical parameter classifier of clinical parameters combined DLR, particularly with a high specificity of 0.917. The area under the receiver operating characteristic curve (AUC) for the test cohort was 0.810.Conclusion: Our study provides a non-invasive imaging biomarker to predict HER2 expression status in breast cancer patients.
Background: An accurate preoperative assessment of cervical lymph node metastasis (LNM) is important for choosing an optimal therapeutic strategy for papillary thyroid carcinoma (PTC) patients. This study aimed to develop and validate two ultrasound (US) nomograms for the individual prediction of central and lateral compartment LNM in patients with PTC. Methods: A total of 720 PTC patients from 3 institutions were enrolled in this study. They were categorized into a primary cohort, an internal validation, and two external validation cohorts. Radiomics features were extracted from conventional US images. LASSO regression was used to select optimized features to construct the radiomics signature. Two nomograms integrating independent clinical variables and radiomics signature were established with multivariate logistic regression. The performance of the nomograms was assessed with regard to discrimination, calibration, and clinical usefulness. Results: The radiomics scores were significantly higher in patients with central/lateral LNM. A radiomics nomogram indicated good discrimination for central compartment LNM, with an area under the curve (AUC) of 0.875 in the training set, the corresponding value in the validation sets were 0.856, 0.870 and 0.870, respectively. Another nomogram for predicting lateral LNM also demonstrated good performance with an AUC of 0.938 and 0.905 in the training and internal validation cohorts, respectively. The AUC for the two external validation cohorts were 0.881 and 0.903, respectively. The clinical utility of the nomograms was confirmed by the decision curve analysis. Conclusion: The nomograms proposed here have favorable performance for preoperatively predicting cervical LNM, hold promise for optimizing the personalized treatment, and might greatly facilitate the decision-making in clinical practice.
Cancer‐associated fibroblasts (CAFs) play a pivotal role in inducing photothermal therapy (PTT) resistance of triple‐negative breast cancer (TNBC), but with unclear mechanism. Herein, aminoethyl anisamide‐modified nano‐biomimetic low‐density lipoprotein (A‐aLDL) is used to target deliver the PTT agent and artesunate (ARS) to both CAFs and cancer cells. Though CAFs are sensitive to PTT and notably transition to heat‐resistant phenotype, the formed protective barrier is destroyed by ARS. Subsequently, the outstanding anti‐tumor effects are achieved through PTT in multiple models with such kind of combination therapy. Interestingly, the mechanism is discovered that serine metabolism plays a major role in CAF resistance through spatially omics. ARS disrupts serine homeostasis, thereby attenuating the cascade activity of GTPases in MAPK pathway. Meanwhile, MAP2K7 is the most potential target for sensitizing PTT. By integrating ARS with PTT agents, the serine‐MAPK axis in CAFs is successfully modulated, thereby overcoming PTT resistance in TNBC therapy.
13 February 2023 in Computers in Biology and Medicine